| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0733-8619(08)80006-0 |
| P8608 | Fatcat ID | release_iqdzil6flfhebhx3u665zedhpq |
| P698 | PubMed publication ID | 18603169 |
| P2093 | author name string | Geoffrey Sheean | |
| P2860 | cites work | Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene | Q28270793 |
| Functional architecture of basal ganglia circuits: neural substrates of parallel processing | Q29618729 | ||
| Acute dystonia induced by drug treatment | Q33726345 | ||
| Molecular effects of dopamine on striatal-projection pathways | Q33923086 | ||
| Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful | Q34464433 | ||
| Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required | Q34464439 | ||
| Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia | Q34467214 | ||
| Pathophysiology of dystonia: a neuronal model | Q34596357 | ||
| Circuits and circuit disorders of the basal ganglia | Q34599488 | ||
| Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors. | Q34698824 | ||
| The neostriatal mosaic: multiple levels of compartmental organization | Q35318347 | ||
| Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia | Q35463218 | ||
| What are the determinants of quality of life in people with cervical dystonia? | Q35466924 | ||
| Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument | Q35572552 | ||
| ??? | Q64781363 | ||
| Nondopaminergic mechanisms in levodopa-induced dyskinesia | Q36188913 | ||
| Treatment of cervical dystonia with botulinum toxins | Q36370621 | ||
| Oscillations in the basal ganglia under normal conditions and in movement disorders | Q36531778 | ||
| Cervical dystonia responsive to acoustic and galvanic vestibular stimulation | Q39350238 | ||
| Dopa-responsive dystonia | Q40426956 | ||
| The basal ganglia: focused selection and inhibition of competing motor programs | Q41326238 | ||
| Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque | Q42474145 | ||
| Posteroventral medial pallidotomy in advanced Parkinson's disease. | Q42547342 | ||
| High psychiatric comorbidity in spasmodic torticollis: a controlled study | Q48238452 | ||
| The pathophysiology of primary dystonia | Q48423358 | ||
| The neurophysiology of dystonia | Q48459680 | ||
| Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. | Q48491525 | ||
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. | Q48501739 | ||
| Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. | Q51900325 | ||
| CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. | Q53211725 | ||
| Impact of cervical dystonia on quality of life. | Q53419346 | ||
| Trick maneuvers in cervical dystonia: investigation of movement- and touch-related changes in polymyographic activity. | Q53957067 | ||
| Long‐term botulinum toxin treatment increases employment rate in patients with cervical dystonia | Q61679863 | ||
| MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia | Q64934947 | ||
| Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin | Q71960209 | ||
| Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming | Q73546533 | ||
| Frequency analysis of EMG activity in patients with idiopathic torticollis | Q73585967 | ||
| Descending control of muscles in patients with cervical dystonia | Q74448521 | ||
| The impact of blepharospasm and cervical dystonia on health-related quality of life and depression | Q74519545 | ||
| Exteroceptive and interoceptive stimuli in dystonia | Q74615226 | ||
| Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group | Q77878458 | ||
| Relation between depression and anxiety in dystonic patients: implications for clinical management | Q78471841 | ||
| Complex mechanisms of sensory tricks in cervical dystonia | Q79910048 | ||
| The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment | Q81366644 | ||
| P921 | main subject | cervical dystonia | Q6152510 |
| P304 | page(s) | 66-76 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Neurologic Clinics | Q15756619 |
| P1476 | title | Cervical dystonia: unresolved issues and future challenges | |
| P478 | volume | 26 Suppl 1 |
| Q34067456 | Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) | cites work | P2860 |
Search more.